Add Spironolactone as the Fourth Agent
For this patient with resistant hypertension on losartan 50mg and HCTZ 25mg daily with persistent evening systolic BP of 170 mmHg, add spironolactone 12.5-25mg daily as the fourth antihypertensive agent 1, 2.
Rationale for Spironolactone
This patient meets criteria for resistant hypertension (BP above target on 3+ medications including a diuretic). The most recent Hypertension Canada 2020 guidelines specifically identify spironolactone as providing the greatest BP-lowering effect when added to existing multidrug regimens 2.
The evidence is compelling:
- Spironolactone added to existing regimens (including ARB + diuretic) lowered BP by 25/12 mmHg on average 1
- This benefit occurred regardless of baseline aldosterone levels, plasma renin activity, or aldosterone/renin ratio 1
- The effect was similar in both African American and white patients 1
Before Adding Medication: Critical Steps
First, rule out pseudoresistance:
- Confirm elevated BP with home BP monitoring or ambulatory BP monitoring (not just office readings) 2
- Assess medication adherence directly 2
- Screen for obstructive sleep apnea if not already done 2
- Review for interfering medications, particularly NSAIDs - withdraw or minimize these 1
Optimize Current Regimen First
Before adding a fourth agent, consider:
Increase losartan to 100mg daily - the FDA label shows doses of 50-100mg provide better BP control than 50mg alone, with 100mg being the maximum effective dose 3
Consider switching HCTZ to a thiazide-like diuretic (chlorthalidone or indapamide) - guidelines specifically recommend thiazide-like diuretics as superior 2
Verify timing - if not already doing so, consider splitting to twice-daily dosing of losartan, as twice-daily dosing at 50-100mg/day gives consistently larger trough responses than once-daily 3
If Optimization Fails: Add Spironolactone
Starting dose: 12.5-25mg daily 1
- Can titrate up to 50mg daily based on response 1
- Monitor potassium and creatinine closely (risk of hyperkalemia when combined with ARB)
- Expect average BP reduction of 25/12 mmHg 1
Alternative Fourth Agents (If Spironolactone Contraindicated)
Per 2020 guidelines, other options with proven efficacy include 2:
- Amiloride (especially if concerned about gynecomastia from spironolactone)
- Bisoprolol
- Doxazosin
- Clonidine
However, spironolactone demonstrates the greatest BP-lowering effect among these options.
Common Pitfalls to Avoid
- Don't add calcium channel blocker or another ARB - studies show adding a diuretic or CCB to an ARB is more effective than adding an ACE inhibitor (same-class combination) 1
- Monitor for hyperkalemia - particularly important given ARB + spironolactone combination
- Don't assume white coat hypertension - but do confirm with out-of-office measurements 2
- Address sodium intake - dietary sodium reduction remains beneficial in resistant hypertension 2